Gene expression profiling of clinical stages II and III breast cancer
Braz. j. med. biol. res
;
39(8): 1101-1113, Aug. 2006. tab
Article
in English
| LILACS
| ID: lil-433168
RESUMO
Clinical stage (CS) is an established indicator of breast cancer outcome. In the present study, a cDNA microarray platform containing 692 genes was used to identify molecular differences between CSII and CSIII disease. Tumor samples were collected from patients with CSII or CSIII breast cancer, and normal breast tissue was collected from women without invasive cancer. Seventy-eight genes were deregulated in CSIII tumors and 22 in CSII tumors when compared to normal tissue, and 20 of them were differentially expressed in both CSII and CSIII tumors. In addition, 58 genes were specifically altered in CSIII and expression of 6 of them was tested by real time RT-PCR in another cohort of patients with CSII or CSIII breast cancer and in women without cancer. Among these genes, MAX, KRT15 and S100A14, but not APOBEC3G or KRT19, were differentially expressed on both CSIII and CSII tumors as compared to normal tissue. Increased HMOX1 levels were detected only in CSIII tumors and may represent a molecular marker of this stage. A clear difference in gene expression pattern occurs at the normal-to-cancer transition; however, most of the differentially expressed genes are deregulated in tumors of both CS (II and III) compared to normal breast tissue.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Breast Neoplasms
/
Gene Expression Regulation, Neoplastic
/
Gene Expression Profiling
Type of study:
Observational study
Limits:
Adult
/
Aged
/
Female
/
Humans
Language:
English
Journal:
Braz. j. med. biol. res
Journal subject:
Biology
/
Medicine
Year:
2006
Type:
Article
/
Congress and conference
/
Project document
Affiliation country:
Brazil
Institution/Affiliation country:
Hospital Amaral Carvalho/BR
/
Hospital do Câncer A. C. Camargo/BR
/
Hospital do Câncer A. C.Camargo/BR
/
Hospital do Câncer A.C/BR
/
Instituto Brasileiro de Controle do Câncer/BR
/
Instituto Ludwig de Pesquisa sobre o Câncer/BR
/
Universidade de São Paulo/BR
Similar
MEDLINE
...
LILACS
LIS